Login to Your Account



Financings Roundup


Tuesday, July 3, 2012
• Corcept Therapeutics Inc., of Menlo Park, Calif., disclosed plans for an underwritten public offering of 11 million shares of common stock.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription